Press ReleaseDx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the Development of a Universal Vaccine – Preparing for Phase 2 Global Trials of a Ferritin Platform-Based Virus-Like Particle… CISION PRNewswireJanuary 13, 2025
Press ReleaseNeuromodulation Wristband ObeEnd Reduces Heart Rate and Perceived Exercise Exertion VANCOUVER, BC, Jan. 13, 2025 /PRNewswire/ — WAT Medical Enterprise collaborated with… CISION PRNewswireJanuary 13, 2025
Addentax Invests Equity Stake in Fresh Food Marketing Solution Provider, Well Information Technology Corporation SHENZHEN, China, Jan. 13, 2025 /PRNewswire/ — Addentax Group Corp. ("Addentax" or… CISION PRNewswireJanuary 13, 2025
Press ReleaseLG Innotek Reasserts Its Leadership in the Future Mobility Market at CES 2025 Exhibition booth attracts 65,000 cumulative visitors, showcasing innovative mobility components Innovative technologies… CISION PRNewswireJanuary 13, 2025
Press ReleaseWXT Surged 101% in 24 hours, And the Price Exceeded $0.339.Why Can WXT Go to the Moon? SINGAPORE, Jan. 13, 2025 /PRNewswire/ — Platform tokens have gained increased attention… CISION PRNewswireJanuary 13, 2025
CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial SHANGHAI, Jan. 13, 2025 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code:… CISION PRNewswireJanuary 13, 2025
Nature's Miracle Holding, Inc. Announces Up to $29.7 Million Financing ONTARIO, Calif., Jan. 13, 2025 /PRNewswire/ — Nature’s Miracle Holding, Inc. (Nasdaq:… CISION PRNewswireJanuary 13, 2025
China Liberal Education Holdings Limited Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency BEIJING, Jan. 13, 2025 /PRNewswire/ — China Liberal Education Holdings Limited ("China Liberal"… CISION PRNewswireJanuary 13, 2025
